Table 2. Median overall survival from the first CRS/HIPEC classified by histologic type.
| Author (citation) | Median overall survival | Appendiceal | Mesothelioma | Ovarian | Colorectal | Other |
|---|---|---|---|---|---|---|
| Votanopoulos et al. (10) | 32.2 [62] | 85.3 [33] | 52.9 [7] | 60.1 [8] | 137.4 [4] | − [10] |
| Golse et al. (11) | 140.0 [30] | − [6] | − [3] | − [9] | − [8] | − [4] |
| Wong et al. (12) | 26.0 [7] | 107.0 [3] | 39.0 [1] | 23.5 [2] | 11.0 [1] | − |
Data presented as overall survival in months (number of affected individuals). CRS, cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy.